The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
ERK implication in cell cycle regulation
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Phosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268
Yeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W. C., Stukenberg, P. T., Shenolikar, S., Uchida, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1110 · Cited by 791
Franza, B. R., Maruyama, K., Garrels, J. I., & Ruley, H. E. (1986) · Cell · doi:10.1016/0092-8674(86)90462-9 · Cited by 166
Research works printed but not linked: 101
- Boulton, 1991, ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF, Cell, 65, 663, 10.1016/0092-8674(91)90098-J · DOI · Paper page
- Cooper, 1984, Diverse mitogenic agents induce the phosphorylation of two related 42,000-dalton proteins on tyrosine in quiescent chick cells, Mol. Cell Biol., 4, 30, 10.1128/MCB.4.1.30 · DOI · Paper page
- Kohno, 1986, Alpha-thrombin-induced tyrosine phosphorylation of 43,000- and 41,000-Mr proteins is independent of cytoplasmic alkalinization in quiescent fibroblasts, Biochem. J., 238, 451, 10.1042/bj2380451 · DOI
- Meloche, 1992, Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity, Mol. Endocrinol., 6, 845
- Cook, 1996, Kinetic and biochemical correlation between sustained p44ERK1 (44 kDa extracellular signal-regulated kinase 1) activation and lysophosphatidic acid-stimulated DNA synthesis in Rat-1 cells, Biochem. J., 320, 237
- Kahan, 1992, Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. Evidence for thrombin-induced signals different from phosphoinositide turnover and adenylylcyclase inhibition, J. Biol. Chem., 267, 13369
- Tamemoto, 1992, Biphasic activation of two mitogen-activated protein kinases during the cell cycle in mammalian cells, J. Biol. Chem., 267, 20293
- Vouret-Craviari, 1993, Differential activation of p44mapk (ERK1) by alpha-thrombin and thrombin-receptor peptide agonist, Biochem. J., 289, 209, 10.1042/bj2890209 · DOI · Paper page
- Roovers, 2000, Integrating the MAP kinase signal into the G1 phase cell cycle machinery, BioEssays, 22, 818, 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.0.CO;2-6 · DOI · Paper page
- Yamamoto, 2006, Continuous ERK activation downregulates antiproliferative genes throughout G1 phase to allow cell-cycle progression, Curr. Biol., 16, 1171, 10.1016/j.cub.2006.04.044 · DOI · Paper page
- Jones, 2001, Growth-factor-dependent mitogenesis requires two distinct phases of signalling, Nat. Cell Biol., 3, 165, 10.1038/35055073 · DOI · Paper page
- Dikic, 1994, PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation, Curr. Biol., 4, 702, 10.1016/S0960-9822(00)00155-X · DOI · Paper page
- Traverse, 1994, EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor, Curr. Biol., 4, 694, 10.1016/S0960-9822(00)00154-8 · DOI · Paper page
- Cagnol, 2006, Prolonged activation of ERK1,2 induces FADD-independent caspase 8 activation and cell death, Apoptosis, 11, 337, 10.1007/s10495-006-4065-y · DOI
- Stanciu, 2002, Prolonged nuclear retention of activated extracellular signal-regulated protein kinase promotes cell death generated by oxidative toxicity or proteasome inhibition in a neuronal cell line, J. Biol. Chem., 277, 4010, 10.1074/jbc.M104479200 · DOI
- Xiao, 2002, Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases, Cancer Res., 62, 3615
- Tang, 2002, ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53, J. Biol. Chem., 277, 12710, 10.1074/jbc.M111598200 · DOI · Paper page
- Hsu, 2005, Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells, J. Pharmacol. Exp. Ther., 313, 333, 10.1124/jpet.104.078808 · DOI · Paper page
- Calcabrini, 2006, Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate, Carcinogenesis, 27, 1699, 10.1093/carcin/bgl044 · DOI
- Keyse, 1998, Protein phosphatases and the regulation of MAP kinase activity, Semin. Cell Dev. Biol., 9, 143, 10.1006/scdb.1997.0219 · DOI
- Pages, 1993, Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation, Proc. Natl. Acad. Sci. U. S. A., 90, 8319, 10.1073/pnas.90.18.8319 · DOI · Paper page
- Dudley, 1995, A synthetic inhibitor of the mitogen-activated protein kinase cascade, Proc. Natl. Acad. Sci. U. S. A., 92, 7686, 10.1073/pnas.92.17.7686 · DOI · Paper page
- Kamakura, 1999, Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus, J. Biol. Chem., 274, 26563, 10.1074/jbc.274.37.26563 · DOI · Paper page
- Mody, 2001, Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway, FEBS Lett., 502, 21, 10.1016/S0014-5793(01)02651-5 · DOI · Paper page
- Squires, 2002, Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1, Biochem. J., 366, 673, 10.1042/bj20020372 · DOI
- Davies, 2000, Specificity and mechanism of action of some commonly used protein kinase inhibitors, Biochem. J., 351, 95, 10.1042/0264-6021:3510095 · doi:10.1042/0264-6021:3510095 · Paper page
- Fischer, 2005, The role of erk1 and erk2 in multiple stages of T cell development, Immunity, 23, 431, 10.1016/j.immuni.2005.08.013 · DOI · Paper page
- Brunet, 1999, Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry, EMBO J., 18, 664, 10.1093/emboj/18.3.664 · DOI · Paper page
- Formstecher, 2001, PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase, Dev. Cell, 1, 239, 10.1016/S1534-5807(01)00035-1 · DOI · Paper page
- Gervais, 2006, Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15, Mol. Biol. Cell, 17, 3940, 10.1091/mbc.E06-06-0501 · DOI
- Graves, 2000, Regulation of carbamoyl phosphate synthetase by MAP kinase, Nature, 403, 328, 10.1038/35002111 · DOI · Paper page
- Sigoillot, 2005, Nuclear localization and mitogen-activated protein kinase phosphorylation of the multifunctional protein CAD, J. Biol. Chem., 280, 25611, 10.1074/jbc.M504581200 · DOI
- Lenormand, 1998, Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins, J. Cell Biol., 142, 625, 10.1083/jcb.142.3.625 · DOI · Paper page
- Soloaga, 2003, MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14, EMBO J., 22, 2788, 10.1093/emboj/cdg273 · DOI · Paper page
- Stefanovsky, 2006, Growth factor signaling regulates elongation of RNA polymerase I transcription in mammals via UBF phosphorylation and r-chromatin remodeling, Mol. Cell, 21, 629, 10.1016/j.molcel.2006.01.023 · DOI · Paper page
- Stefanovsky, 2006, ERK modulates DNA bending and enhancesome structure by phosphorylating HMG1-boxes 1 and 2 of the RNA polymerase I transcription factor UBF, Biochemistry, 45, 3626, 10.1021/bi051782h · DOI
- Waskiewicz, 1999, Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo, Mol. Cell Biol., 19, 1871, 10.1128/MCB.19.3.1871 · DOI · Paper page
- Ueda, 2004, Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development, Mol. Cell Biol., 24, 6539, 10.1128/MCB.24.15.6539-6549.2004 · DOI · Paper page
- Wullschleger, 2006, TOR signaling in growth and metabolism, Cell, 124, 471, 10.1016/j.cell.2006.01.016 · DOI · Paper page
- Inoki, 2005, Signaling by target of rapamycin proteins in cell growth control, Microbiol. Mol. Biol. Rev., 69, 79, 10.1128/MMBR.69.1.79-100.2005 · DOI · Paper page
- Roux, 2004, Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase, Proc. Natl. Acad. Sci. U. S. A., 101, 13489, 10.1073/pnas.0405659101 · DOI · Paper page
- Lavoie, 1996, Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway, J. Biol. Chem., 271, 20608, 10.1074/jbc.271.34.20608 · DOI · Paper page
- Weber, 1997, Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase, Biochem. J., 326, 61, 10.1042/bj3260061 · DOI · Paper page
- Brown, 1998, Fos family members induce cell cycle entry by activating cyclin D1, Mol. Cell Biol., 18, 5609, 10.1128/MCB.18.9.5609 · DOI · Paper page
- Burch, 2004, An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry, Mol. Cell Biol., 24, 4696, 10.1128/MCB.24.11.4696-4709.2004 · DOI
- Albanese, 1995, Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions, J. Biol. Chem., 270, 23589, 10.1074/jbc.270.40.23589 · DOI · Paper page
- Preston, 2000, Apoptotic response to growth factor deprivation involves cooperative interactions between c-Fos and p300, Cell Death Differ., 7, 215, 10.1038/sj.cdd.4400637 · DOI
- Baluchamy, 2003, Repression of c-Myc and inhibition of G1 exit in cells conditionally overexpressing p300 that is not dependent on its histone acetyltransferase activity, Proc. Natl. Acad. Sci. U. S. A., 100, 9524, 10.1073/pnas.1633700100 · DOI
- Balmanno, 1999, Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells, Oncogene, 18, 3085, 10.1038/sj.onc.1202647 · DOI · Paper page
- Gille, 1995, ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation, EMBO J., 14, 951, 10.1002/j.1460-2075.1995.tb07076.x · DOI · Paper page
- Murphy, 2004, A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration, Mol. Cell. Biol., 24, 144, 10.1128/MCB.24.1.144-153.2004 · DOI · Paper page
- Murphy, 2002, Molecular interpretation of ERK signal duration by immediate early gene products, Nat. Cell Biol., 4, 556, 10.1038/ncb822 · DOI · Paper page
- Volmat, 2001, The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases, J. Cell Sci., 114, 3433
- Seth, 1991, A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression, J. Biol. Chem., 266, 23521
- Daksis, 1994, Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle, Oncogene, 9, 3635
- Sherr, 1999, CDK inhibitors: positive and negative regulators of G1-phase progression, Genes Dev., 13, 1501, 10.1101/gad.13.12.1501 · DOI · Paper page
- Keenan, 2001, Cyclin-dependent kinase 2 nucleocytoplasmic translocation is regulated by extracellular regulated kinase, J. Biol. Chem., 276, 22404, 10.1074/jbc.M100409200 · DOI
- Lents, 2002, Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2, J. Biol. Chem., 277, 47469, 10.1074/jbc.M207425200 · DOI
- Yoshida, 2003, Mice lacking a transcriptional corepressor Tob are predisposed to cancer, Genes Dev., 17, 1201, 10.1101/gad.1088003 · DOI
- Weitzman, 2000, JunD protects cells from p53-dependent senescence and apoptosis, Mol. Cell, 6, 1109, 10.1016/S1097-2765(00)00109-X · DOI · Paper page
- Wright, 1999, Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts, Proc. Natl. Acad. Sci. U. S. A., 96, 11335, 10.1073/pnas.96.20.11335 · DOI · Paper page
- Roberts, 2002, Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis, Mol. Cell Biol., 22, 7226, 10.1128/MCB.22.20.7226-7241.2002 · DOI
- Walsh, 2003, Phosphorylation of the cyclin b1 cytoplasmic retention sequence by mitogen-activated protein kinase and Plx, Mol. Cancer Res., 1, 280
- Palmer, 1998, A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1, EMBO J., 17, 5037, 10.1093/emboj/17.17.5037 · DOI · Paper page
- Liu, 1999, Overproduction of human Myt1 kinase induces a G2 cell cycle delay by interfering with the intracellular trafficking of Cdc2–cyclin B1 complexes, Mol. Cell. Biol., 19, 5113, 10.1128/MCB.19.7.5113 · DOI
- Yan, 2005, BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation, Oncogene, 24, 3285, 10.1038/sj.onc.1208492 · DOI
- Rahmouni, 2006, Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence, Nat. Cell Biol., 8, 524, 10.1038/ncb1398 · DOI
- Shapiro, 1998, Activation of the MKK/ERK pathway during somatic cell mitosis: direct interactions of active ERK with kinetochores and regulation of the mitotic 3F3/2 phosphoantigen, J. Cell Biol., 142, 1533, 10.1083/jcb.142.6.1533 · DOI · Paper page
- Zecevic, 1998, Active MAP kinase in mitosis: localization at kinetochores and association with the motor protein CENP-E, J. Cell Biol., 142, 1547, 10.1083/jcb.142.6.1547 · DOI · Paper page
- Cha, 2004, Phosphorylation regulates nucleophosmin targeting to the centrosome during mitosis as detected by cross-reactive phosphorylation-specific MKK1/MKK2 antibodies, Biochem. J., 378, 857, 10.1042/bj20031173 · DOI
- Hayne, 2004, MEK inhibition and phosphorylation of serine 4 on B23 are two coincident events in mitosis, Biochem. Biophys. Res. Commun., 321, 675, 10.1016/j.bbrc.2004.07.024 · DOI
- Willard, 2001, MEK, ERK, and p90RSK are present on mitotic tubulin in Swiss 3T3 cells: a role for the MAP kinase pathway in regulating mitotic exit, Cell. Signal., 13, 653, 10.1016/S0898-6568(01)00185-1 · DOI
- Hirakawa, 1988, Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene, Proc. Natl. Acad. Sci. U. S. A., 85, 1519, 10.1073/pnas.85.5.1519 · DOI
- Samuels, 1993, Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase, Mol. Cell. Biol., 13, 6241, 10.1128/MCB.13.10.6241 · DOI · Paper page
- Sewing, 1997, High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1, Mol. Cell. Biol., 17, 5588, 10.1128/MCB.17.9.5588 · DOI · Paper page
- Woods, 1997, Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1, Mol. Cell. Biol., 17, 5598, 10.1128/MCB.17.9.5598 · DOI · Paper page
- Park, 2000, A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes, Mol. Biol. Cell, 11, 2915, 10.1091/mbc.11.9.2915 · DOI
- Touitou, 2001, A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome, EMBO J., 20, 2367, 10.1093/emboj/20.10.2367 · DOI · Paper page
- Coleman, 2003, Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation, EMBO J., 22, 2036, 10.1093/emboj/cdg189 · DOI
- Alt, 2002, p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export, J. Biol. Chem., 277, 8517, 10.1074/jbc.M108867200 · DOI · Paper page
- Haluska, 2006, Genetic alterations in signaling pathways in melanoma, Clin. Cancer Res., 12, 2301s, 10.1158/1078-0432.CCR-05-2518 · DOI · Paper page
- Mirza, 2004, Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT, Mol. Cell. Biol., 24, 10868, 10.1128/MCB.24.24.10868-10881.2004 · DOI
- Yang, 2001, Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc, Oncogene, 20, 1688, 10.1038/sj.onc.1204245 · DOI · Paper page
- O'Hagan, 2000, Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression, Genes Dev., 14, 2185, 10.1101/gad.827200 · DOI · Paper page
- Medema, 2000, AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1, Nature, 404, 782, 10.1038/35008115 · DOI · Paper page
- Stahl, 2002, The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2, J. Immunol., 168, 5024, 10.4049/jimmunol.168.10.5024 · DOI · Paper page
- Hoshino, 1999, Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors, Oncogene, 18, 813, 10.1038/sj.onc.1202367 · DOI · Paper page
- Sebolt-Leopold, 1999, Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo, Nat. Med., 5, 810, 10.1038/10533 · DOI · Paper page
- Karasarides, 2004, B-RAF is a therapeutic target in melanoma, Oncogene, 23, 6292, 10.1038/sj.onc.1207785 · DOI · Paper page
- Solit, 2006, BRAF mutation predicts sensitivity to MEK inhibition, Nature, 439, 358, 10.1038/nature04304 · DOI · Paper page
- Rinehart, 2004, Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer, J. Clin. Oncol., 22, 4456, 10.1200/JCO.2004.01.185 · DOI · Paper page
- Kohno, 2006, Targeting the ERK signaling pathway in cancer therapy, Ann. Med., 38, 200, 10.1080/07853890600551037 · DOI · Paper page
- Klein, 2006, The Effects of a Novel MEK Inhibitor PD184161 on MEK-ERK Signaling and Growth in Human Liver Cancer, Neoplasia, 8, 1, 10.1593/neo.05373 · DOI
- Fujioka, 2006, Dynamics of the Ras/ERK MAPK cascade as monitored by fluorescent probes, J. Biol. Chem., 281, 8917, 10.1074/jbc.M509344200 · DOI · Paper page
- Lim, 2005, Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance, Cancer Cell, 8, 381, 10.1016/j.ccr.2005.10.014 · DOI · Paper page
- Jordan, 2006, Cancer stem cells, N. Engl. J. Med., 355, 1253, 10.1056/NEJMra061808 · DOI · Paper page
- Burdon, 1999, Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells, Dev. Biol., 210, 30, 10.1006/dbio.1999.9265 · DOI · Paper page
- Burdon, 2002, Signalling, cell cycle and pluripotency in embryonic stem cells, Trends Cell Biol., 12, 432, 10.1016/S0962-8924(02)02352-8 · DOI · Paper page
- Hoshino, 2001, Blockade of the extracellular signal-regulated kinase pathway induces marked G1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated: up-regulation of p27(Kip1), J. Biol. Chem., 276, 2686, 10.1074/jbc.M006132200 · DOI
- Gysin, 2005, Pharmacologic inhibition of RAF→MEK→ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1, Cancer Res., 65, 4870, 10.1158/0008-5472.CAN-04-2848 · DOI
- Collisson, 2003, Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade, Cancer Res., 63, 5669
Cited by
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
Wee, P., & Wang, Z. (2017) · Cancers · doi:10.3390/cancers9050052 · Cited by 2,027
The extracellular matrix modulates the hallmarks of cancer
Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014) · EMBO reports · doi:10.15252/embr.201439246 · Cited by 1,996
ERK signalling: A master regulator of cell behaviour, life and fate
Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185
Provenzano, P. P., Inman, D. R., Eliceiri, K. W., & Keely, P. J. (2009) · Oncogene · doi:10.1038/onc.2009.299 · Cited by 675
Using Optogenetics to Interrogate the Dynamic Control of Signal Transmission by the Ras/Erk Module
Toettcher, J. E., Weiner, O. D., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.11.004 · Cited by 537
Metadata
- Authors
- Chambard, J.-C., Lefloch, R., Pouysségur, J., & Lenormand, P.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 1773
- Issue
- 8
- Pages
- 1299-1310
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2122231684
- Cited by
- 750
- References
- 5
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2178 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ERK implication in cell cycle regulation. https://app.cochat.ai/papers/10.1016/j.bbamcr.2006.11.010
- The paper
- Chambard, J.-C., Lefloch, R., Pouysségur, J., & Lenormand, P. (2007). ERK implication in cell cycle regulation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. https://doi.org/10.1016/j.bbamcr.2006.11.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.